CompanyKRYSNasdaqPittsburgh, PA

Krystal Biotech, Inc.

Krystal Biotech develops genetic medicines for diseases with high unmet medical needs.

SEC EDGAR ClinicalTrials.gov krystalbio.com

S-1Sep 11Latest SEC filing

Aug 3Latest story

August 2026

Krystal Biotech posts second-quarter results, outlines multiple late-2026 pipeline readouts

Aug 3Quarterly updateKrystal Biotech, Inc.

July 2026

Krystal Biotech registers early-phase trial of KB111 gene therapy for Hailey-Hailey Disease

Jul 21Trial updateKB111 Krystal Biotech, Inc.